DJ Pharnext announces that Neovacs has set-up a management trust to manage the Pharnext securities issued and the rights and obligations of Neovacs under the financing agreement signed on September 30th
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement
DJ Pharnext executes a financing agreement with Néovacs for EUR 20.7 million net to further develop PXT3003 for Charcot-Marie-Tooth disease type 1A Pharnext Pharnext executes a financing agreement
Regulatory News: Advicenne (Euronext Growth Paris ALDVI -FR0013296746) (Paris:ALDVI), a pharmaceutical company specializing in the development and commercialization of innovative treatments for those
DJ Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022 Pharnext Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from